Special Issue
Pathogenesis and diagnostic modalities in cancer
Submission Deadline: 31 December 2018
Articles: 3
Special Issue Editor
Guest Editor
Wei Qin
Professor, Cancer Institute, No. 25/2200 Xietu Road, Shanghai 200032, P. R. China
Expertise: 32 publications, 4 grants, Editor of Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see


Cancer, Diagnostics, Molecular Biology
Share This Special Issue
Published Papers (3 papers)
Open Access

p53 and P-glycoprotein influence chemoresistance in hepatocellular carcinoma

ShengLei Li, Ming Gao, ZongMing Li, LiJie Song, XianZheng Gao, Jing Han, Feng Wang, YongFang Chen, WenCai Li, JianPing Yang
Frontiers in Bioscience-Elite Volume 10 Issue 3, pp.461-468
Managing Editor: Wei Qin
DOI: 10.2741/E833 Published: 01 June 2018
Open Access

Adenovirus KH901 promotes 5-FU antitumor efficacy and S phase in LoVo cells

Wei Peng, Jin Li, XG Yin, JF Xu, LZ Cheng
Frontiers in Bioscience-Elite Volume 4 Issue 7, pp.2389-2395
Managing Editor: Wei Qin
DOI: 10.2741/E550 Published: 01 June 2012
Open Access

CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance

Jianlong Zhu, Guoling Zhang, Huijuan Lu
Frontiers in Bioscience-Elite Volume 4 Issue 8, pp.2645-2651
Managing Editor: Wei Qin
DOI: 10.2741/E580 Published: 01 June 2012